Policymakers, national control program professionals, and practitioners problem solve and exchange best practices in this community with the goal of improving the prevention, management and treatment of malaria.
Thank you Dr. Pierre for sharing this article. Malaria transmission-blocking vaccines (mTBVs) should be the more promising malaria vaccine group as they target a bottleneck phase of the parasite. The only challenge with mTBVs might be compliance when immunizing, since they protect indirectly by preventing transmission to the next person. read more
Thank you Dr. Pierre. Of course it has to be remembered that humanity has been awaiting the malaria vaccine for decades (see attachment). Even at the time of the classical resource book edited by Prof. Targett, there had already been more decades of waiting for the malaria vaccine. We will ... read more
Hello Frederick, Thank you for your response. The following passage from the methods used in the study answers your questions: "Participants received combined artemether and lumefantrine (four tablets, each containing 20 mg artemether and 120 mg lumefantrine, given twice per day over 3 days for a total of six doses) ... read more
Cepheid; Cepheid, Inc.Work Locations
Liverpool School of Tropical MedicineWork Locations